Sir Leszek Borysiewicz

Sir Leszek Borysiewicz
Name	Leszek Borysiewicz
Honorific prefix	Sir
Birth date	1949
Birth place	Cardiff, Wales
Nationality	British
Occupation	Immunologist, Physician, Academic, Administrator
Alma mater	Cambridge, London

Sir Leszek Borysiewicz

Sir Leszek Borysiewicz is a British clinical immunologist and academic administrator noted for translational vaccine research and leadership in biomedical institutions. He has held senior roles at University of Cambridge, the Medical Research Council, and Wellcome Trust, contributing to vaccine development, research policy, and institutional governance. His work intersects with clinical trials, translational science, public health initiatives, and national research strategy.

Early life and education

Born in Cardiff, Borysiewicz trained in medicine at the University of Cambridge and completed clinical training at the Royal Free Hospital. He undertook postgraduate research at the London School of Hygiene & Tropical Medicine and earned clinical qualifications from the Royal College of Physicians. His formative influences include mentors at Addenbrooke's Hospital, collaborations with researchers at the National Institute for Medical Research, and exposure to vaccine programs linked to the World Health Organization.

Medical and research career

Borysiewicz's research focused on immunology, viral oncology, and vaccine development, including work on human papillomavirus and Cytomegalovirus. He led translational studies linking basic immunology at the MRC Laboratory of Molecular Biology with clinical trials at Addenbrooke's Hospital and the Cambridge Clinical School. His collaborations spanned institutions such as Imperial College London, University College London, King's College London, St George's, University of London, and international centres including the National Institutes of Health and Institut Pasteur. He contributed to projects funded by the Wellcome Trust, the European Commission, and the UK Research and Innovation framework, working on vaccine adjuvants, viral vectors, and immunotherapy approaches related to human immunodeficiency virus and oncogenic viruses. His publications appeared alongside researchers affiliated with the Royal Society, Academy of Medical Sciences, and consortiums connected to the European Molecular Biology Organization.

Leadership at University of Cambridge

As Deputy Vice-Chancellor and later as Vice-Chancellor at the University of Cambridge, he engaged with colleges including Trinity College, Cambridge, King's College, Cambridge, and St Catharine's College, Cambridge, and with faculties such as the School of Clinical Medicine and the Faculty of Biology. He oversaw relationships with external partners like the NHS, Cambridge Biomedical Campus, and industry partners including GlaxoSmithKline and AstraZeneca. His tenure involved capital projects, graduate training initiatives linked to the European Research Council, and partnerships with the Engineering and Physical Sciences Research Council and the Biotechnology and Biological Sciences Research Council.

Chief Executive of the Medical Research Council

As Chief Executive of the MRC, he steered funding priorities across institutes such as the MRC Laboratory of Molecular Biology, the MRC National Institute for Medical Research, and MRC units collaborating with University College London and University of Oxford. He engaged with policy bodies including the Department of Health and Social Care, the Medical Research Foundation, and advisory committees to the Health Research Authority. His leadership addressed translational pipelines connecting basic science to clinical trials overseen by bodies like the National Institute for Health Research, emphasizing partnerships with industry players such as Pfizer and consortia funded under Horizon 2020.

Honours, awards and memberships

Borysiewicz has been recognised by election to the Academy of Medical Sciences and fellowship of the Royal College of Physicians. He received honours including knighthood within the Order of the British Empire and awards from bodies such as the Royal Society and the British Medical Association. He has served on boards and advisory committees for organisations including the Wellcome Trust, the European Vaccine Initiative, and international panels convened by the World Health Organization.

Personal life

He is married and has family ties in Wales and the United Kingdom. Outside professional roles he has engaged with charitable organisations, university governance at collegiate level, and public engagement forums including lectures at the Royal Institution and appearances at events associated with the British Science Association.

Legacy and impact on biomedical research

Borysiewicz's legacy includes strengthening translational research pathways linking institutions such as the MRC Laboratory of Molecular Biology, Addenbrooke's Hospital, and the Cambridge Biomedical Campus, advancing vaccine research on pathogens like human papillomavirus and Cytomegalovirus, and shaping funding strategies across the Medical Research Council and philanthropic funders like the Wellcome Trust. His leadership influenced collaborations between academia and industry involving GlaxoSmithKline and AstraZeneca, informed policy dialogues with the Department of Health and Social Care and the National Institute for Health Research, and contributed to capacity building within the Academy of Medical Sciences and the Royal Society.

Category:British immunologists Category:Knights Bachelor